Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Elevation Oncology stock

Learn how to easily invest in Elevation Oncology stock.

Elevation Oncology is a biotechnology business based in the US. Elevation Oncology shares (ELEV) are listed on the NASDAQ and all prices are listed in US Dollars. Elevation Oncology employs 48 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Elevation Oncology stock

  1. Open a stock trading account. Use our comparison table or choose from our Top Picks.
  2. Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
  3. Search for the stock by name or ticker symbol – ELEV. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Trade stocks and ETFs for $0 and no annual fee
  • Minimum deposit of $10 required
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Elevation Oncology stock price (NASDAQ: ELEV)

Use our graph to track the performance of ELEV stocks over time.

Elevation Oncology shares at a glance

Information last updated 2023-01-25.
Latest market close$1.03
52-week range$0.72 - $5.20
50-day moving average $0.97
200-day moving average $1.52
Wall St. target price$4.17
PE ratio 0.1518
Dividend yield $0 (0%)
Earnings per share (TTM) $6.72

Buy Elevation Oncology stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Elevation Oncology stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Elevation Oncology price performance over time

Historical closes compared with the close of $1.03 from 2023-01-31

1 week (2023-01-26) -0.96%
1 month (2022-12-30) 8.42%
3 months (2022-11-02) -11.21%
6 months (2022-08-02) -8.04%
1 year (2022-02-02) -75.93%
2 years (2021-01-29) N/A
3 years (2020-01-29) N/A
5 years (2018-01-29) N/A

Is Elevation Oncology stock undervalued or overvalued?

Valuing Elevation Oncology stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Elevation Oncology's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Elevation Oncology's P/E ratio

Elevation Oncology's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Elevation Oncology shares trade at around 0x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, Elevation Oncology's P/E ratio is best considered in relation to those of others within the biotechnology industry or those of similar companies.

    Elevation Oncology financials

    Gross profit TTM $0
    Return on assets TTM -39.65%
    Return on equity TTM -79.04%
    Profit margin 0%
    Book value $2.88
    Market capitalisation $23.8 million

    TTM: trailing 12 months

    Elevation Oncology share dividends

    We're not expecting Elevation Oncology to pay a dividend over the next 12 months.

    Elevation Oncology overview

    Elevation Oncology, Inc. , a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York. .

    Frequently asked questions

    What percentage of Elevation Oncology is owned by insiders or institutions?
    Currently 2.184% of Elevation Oncology shares are held by insiders and 71.101% by institutions.
    How many people work for Elevation Oncology?
    Latest data suggests 48 work at Elevation Oncology.
    When does the fiscal year end for Elevation Oncology?
    Elevation Oncology's fiscal year ends in December.
    Where is Elevation Oncology based?
    Elevation Oncology's address is: 888 Seventh Avenue, New York, NY, United States, 10106
    What is Elevation Oncology's ISIN number?
    Elevation Oncology's international securities identification number is: US28623U1016

    More guides on Finder

    Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

    By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

    Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
    Go to site